MDS-AN: An attention-based explainable model for detecting myelodysplastic syndrome using hematological variables

This study aims to develop and evaluate a deep learning model, which is based on an attention architecture for automatic detection of Myelodysplastic Syndromes (MDS), using age, sex and numerical values of 19 variables obtained from peripheral blood samples on a hematologic analyzer used clinical laboratory workflow. A dataset was collected from a total of 223 patients, 121 with MDS and 102 without this condition. The dataset was divided into training, validation, and test sets to train and validate the system. The classification model was developed from scratch using a attention-based architecture specifically designed to handle 21 input variables. In addition, a separate final evaluation was performed with a new group of 150 patients (56 with MDS and 94 with non-MDS) to determine a range of uncertainty and performance metrics. On the test set, the model reached an accuracy of 97.5%, with 95% sensitivity, 95% specificity, 100% precision, and an F1-score of 0.97 for patients with MDS. In the independent evaluation, the model obtained 94.34% sensitivity, 95.60% specificity, 92.59% precision, and an F1-score of 0.935 after applying the uncertainty interval. The explainability analysis, based on Integrated Gradients, SHAP, pairwise interaction analysis, and internal attention mechanisms, consistently highlighted hematological variables associated with MDS, supporting the clinical interpretability of the model’s decisions. The proposed approach enables the automated differentiation of patients with MDS from those with non-MDS. In addition, the integration of explainability techniques strengthens the potential use of the system as a support tool in the clinical recognition of MDS. • A deep learning model for the detecting of MDS using quantitative hematological variables. • Evaluation with independent patients, determining a decision rule and an uncertainty range. • Explainability analysis to identify the most influential variables in the classification. • Concordance between explainability results and established clinical diagnostic criteria for MDS.

Institutions

Publication Details

Journal
Biomedical Signal Processing and Control
Published
2025-12-13
DOI
https://doi.org/10.1016/j.bspc.2025.109416
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MDS-AN: An attention-based explainable model for detecting myelodysplastic syndrome using hematological variables

Biomedical Signal Processing and Control
Acute Myeloid Leukemia Research
article

MDS-AN: An attention-based explainable model for detecting myelodysplastic syndrome using hematological variables

article en

Abstract

This study aims to develop and evaluate a deep learning model, which is based on an attention architecture for automatic detection of Myelodysplastic Syndromes (MDS), using age, sex and numerical values of 19 variables obtained from peripheral blood samples on a hematologic analyzer used clinical laboratory workflow. A dataset was collected from a total of 223 patients, 121 with MDS and 102 without this condition. The dataset was divided into training, validation, and test sets to train and validate the system. The classification model was developed from scratch using a attention-based architecture specifically designed to handle 21 input variables. In addition, a separate final evaluation was performed with a new group of 150 patients (56 with MDS and 94 with non-MDS) to determine a range of uncertainty and performance metrics. On the test set, the model reached an accuracy of 97.5%, with 95% sensitivity, 95% specificity, 100% precision, and an F1-score of 0.97 for patients with MDS. In the independent evaluation, the model obtained 94.34% sensitivity, 95.60% specificity, 92.59% precision, and an F1-score of 0.935 after applying the uncertainty interval. The explainability analysis, based on Integrated Gradients, SHAP, pairwise interaction analysis, and internal attention mechanisms, consistently highlighted hematological variables associated with MDS, supporting the clinical interpretability of the model’s decisions. The proposed approach enables the automated differentiation of patients with MDS from those with non-MDS. In addition, the integration of explainability techniques strengthens the potential use of the system as a support tool in the clinical recognition of MDS. • A deep learning model for the detecting of MDS using quantitative hematological variables. • Evaluation with independent patients, determining a decision rule and an uncertainty range. • Explainability analysis to identify the most influential variables in the classification. • Concordance between explainability results and established clinical diagnostic criteria for MDS.

Biomedical Signal Processing and ControlVol. 115
Josep Carreras Leukaemia Research Institute (ES), Barcelona Graduate School of Mathematics (ES), Hospital Clínic de Barcelona (ES), Universitat Politècnica de Catalunya (ES)
Ministerio de Ciencia e Innovación
Peace, Justice and strong institutions
Openalex Percentile: Top 26%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.